AARDEX Group

What AARDEX Group does

AARDEX Group is a privately held Swiss-headquartered company that provides data-driven medication adherence solutions for clinical trials. Founded in 1984 (firmographics note: 1987) and operating from Sion, Seraing and Boulder, it serves pharmaceutical companies, biotech firms and contract research organizations that need objective, real-time visibility into how trial participants take investigational medicines. Non-adherence is reported to affect up to half of trial participants and undermines the statistical power, regulatory credibility and cost profile of drug development programs.

The company's core asset is the MEMS AS cloud platform, which processes timestamped dosing events captured by a portfolio of smart packaging, dispensers, pen-injector add-ons and an FDA 510(k)-cleared ingestible sensor. More than 70 proprietary algorithms convert that data into dashboards, Key Risk Indicators and ranked lists of participants requiring coaching. The participant-facing MEMS Mobile app is available in 25 languages and across 30 countries, and the system is positioned against ICH E6(R3), HIPAA, GDPR and ISO 27001 standards. Hardware and software are complemented by a professional services team led by Scientific Lead Bernard Vrijens.

AARDEX monetizes through a mix of enterprise software subscriptions for MEMS AS, hardware sales of adherence packaging and devices (much of it sourced from technology partners such as Westrock, Schreiner MediPharm, etecRx, Mevia, Biocorp, medmix, Pill Connect, CMT and OnDosis), and professional services supporting RBQM-aligned adherence strategy. Pricing is quote-based and contracted on multi-year enterprise terms with pharmaceutical sponsors and CROs, with no public list pricing disclosed.

Name

AARDEX Group

Legal name

AARDEX Group

Website

https://aardexgroup.com

Company type

Private

Founded year

1984

Operating status

Operating

Headcount range

11–50 employees

Short description

AARDEX Group provides cloud-based medication adherence software (MEMS AS) and connected packaging/devices for clinical trials, helping pharmaceutical companies, biotech firms and CROs monitor dosing behavior in real time across oral, injectable and inhaled routes.

Ownership category

akta.pro rank

Product category

Clinical Trial Adherence Software

NAICS

Other Scientific and Technical Consulting Services (541690)

SIC

Services-Prepackaged Software (7372)

akta.pro industry

PRIMARYHLALAIAG

Medication Adherence & Therapy Management Platforms (refills, reminders, MTM)

Healthcare & Life Sciences/Telehealth Platforms/Pharmacy-Integrated Telehealth & ePrescribing Platforms

SECONDARYHLAFALAJ

Medication Adherence, Packaging & Fulfillment Services (Blister/Unit-Dose)

Healthcare & Life Sciences/Healthcare Providers & Systems/Pharmacy & Medication Management Services

SECONDARYHLACAKAK

Medication Safety, Pharmacovigilance & Adverse Event Reporting IT

Healthcare & Life Sciences/Digital Health & Health IT/ePrescribing, Medication Management & Pharmacy IT

Keywords

• Medication adherence software
• Clinical trial solutions
• Smart pill packaging
• Pharmaceutical analytics
• Adherence monitoring devices

Headquarters

HQ city

Seraing

HQ country

Belgium

HQ region

Europe

Offices3 records

Markets served

GTM type

B2B

Offering type

Software

Cost components

Technology or R&D, Personnel, Marketing or Sales, Infrastructure, Operations

Revenue model

1. MEMS AS Software Subscription: Cloud-based medication adherence software provided as subscription service to pharmaceutical companies and CROs conducting clinical trials. Powers real-time monitoring and analytics for adherence data.
2. Hardware Sales (Adherence Packaging and Devices): Sale of digitally-enabled medication adherence packaging (MEMS Cap, CleverCap Lite, Pill Connect, Dosepak, Cerepak, Smart Blister Pack, Injectapak) and devices (Mallya, Injay, D-Flex Logbook, OnDosis Dosage Manager). Includes both one-time device sales and ongoing consumables.
3. Professional Services: AARDEX Professional Services Team supports sponsors and CROs in implementing MEMS AS and designing adherence strategies aligned with Risk-Based Quality Management (RBQM). Includes consultation with adherence expert Bernard Vrijens.

Pricing tiers

Go-to-market motion1 record

Distribution channels2 records

Marketing channels5 records

Core offering

AARDEX Group provides a medication adherence ecosystem for clinical trials centered on its cloud-based MEMS AS software platform. The platform ingests real-time medication event data from a network of digitally-enabled smart packaging, electronic pills, and monitoring devices, then applies 70+ proprietary algorithms to detect non-adherence patterns such as missed doses, drug holidays, and overdoses. The offering is sold to pharmaceutical sponsors, biotech firms, and contract research organizations to safeguard trial data integrity and meet ICH E6(R3) Risk-Based Quality Management expectations.

Product overview

AARDEX Group offers a comprehensive medication adherence ecosystem for clinical trials built around its core MEMS AS platform. The ecosystem integrates smart medication adherence packaging (MEMS Cap, CleverCap Lite, Pill Connect, Electronic Dosepak, Cerepak, Smart Blister Wallet, MEMS HH, Injectapak), electronic pills (ID-Cap), and adherence monitoring devices (MEMS Button, Mallya, Injay, D-Flex Logbook, OnDosis Dosage Manager, Medose, Mepill), all synchronized with MEMS AS software for real-time adherence analytics. A participant-facing companion app, MEMS Mobile, provides medication reminders and surveys. The platform supports all routes of drug administration (oral, injectable, inhalable, topical) and is backed by FDA, ICH GCP, HIPAA, GDPR, and ISO 27001 compliance.

Differentiator

Problem solved

Functional benefit

Brands

• MEMS AS: Cloud-based medication adherence software platform powered by over 70 proprietary algorithms for real-time monitoring and analytics in clinical trials.
• MEMS Mobile
• MEMS Cap
• MEMS Button
• MEMS HH (Helping Hand)
• Cerepak
• Dosepak
• ID-Cap
• Injectapak
• CleverCap Lite
• Pill Connect
• Smart Blister Pack
• Medose
• Mepill
• Mallya
• Injay
• D-Flex Logbook
• OnDosis Dosage Manager

Products and services

• MEMS AS Medication Adherence Software Secure, cloud-based medication adherence software platform that processes real-time medication event data from digitally-enabled packaging and devices using 70+ proprietary algorithms to detect missed doses, drug holidays, and overdoses, providing real-time dashboards, Key Risk Indicators, Central Statistical Monitoring, and patient profile visualizations for clinical trial investigators.
• MEMS Mobile App Participant-facing mobile medication adherence app providing customizable reminders, medication scheduling, dosing history, and in-app surveys. Syncs with MEMS AS to provide researchers with adherence data while helping participants stay on track with dosing regimens.
• MEMS Cap Smart Pill Bottle Intelligent track cap with hidden sensors that transforms standard pill bottles into smart pill bottles by recording the date and time of each medication intake, with optional LCD screen, 36-month battery life, and water resistance; CE marked.
• MEMS Helping Hand (MEMS HH) Reusable plastic sleeve with integrated microcircuit technology that records the date and time when a blister pack is removed; CE marked with wireless data transfer capability.
• MEMS Button Electronic medication event monitoring system with a micro-electronic circuit that records the date and time each time the participant presses the button to take medication; CE marked and compatible with most medication packages.

Quantifiable outcome

• 97% accuracy in tracking medication events vs 70% (PK sampling), 60% (pill count), 27% (self-report)
• +3 more outcomes

Named customers4 records

Segments3 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration1 record

AI capability4 records

Feature6 records

Partnerships

Nine partnerships are on record, tiered core.

• WestrockcoreTechnology or IntegrationWestrock provides Electronic Dosepak (EDP), Cerepak, and Injectapak medication adherence packaging solutions integrated with AARDEX Group's MEMS AS software. Westrock's packaging features hidden sensors/microprocessors that capture medication event data for analysis in MEMS AS dashboards.
• Schreiner MediPharmcoreTechnology or IntegrationSchreiner MediPharm provides Smart Blister Pack with concealed trackers in every cavity that capture exact time and date when medication is removed. Data synchronizes with MEMS AS for real-time compliance monitoring in clinical trials.
• Pill ConnectcoreTechnology or IntegrationPill Connect provides smart pill dispenser with advanced features that dispenses the right dose at the right time. Hidden sensors capture date and time pills are dispensed, with data analyzed via MEMS AS using over 70 proprietary algorithms.
• CMTcoreTechnology or IntegrationCMT provides CleverCap Lite digital pill dispenser that harnesses light and sound alerts to remind trial participants to take medications on time. Integrated with MEMS AS for real-time adherence statistics.
• etecRxcoreTechnology or IntegrationetecRx provides ID-Cap electronic pill system with ingestible wireless sensor (ID-Tag) that transmits medication event data to wearable device. FDA 510(k) cleared in 2019 with 98% user engagement rate. Data accessed via MEMS AS.
• MeviacoreTechnology or IntegrationMevia provides Medose and Mepill - cellular medication event monitoring devices that detect pill extraction in real-time. Sustainable smart packaging with no single-use electronics. Data integrates via Mevia's APIs.
• BiocorpcoreTechnology or IntegrationBiocorp provides Mallya (self-injection pen add-on) and Injay (pre-filled syringe add-on) that automatically capture date and time of injections. Integration enables automated injection event data collection for MEMS AS.
• medmixcoreTechnology or Integrationmedmix provides D-Flex Logbook pen injector add-on that automatically captures date and time of injections. Replaces standard cap with sensor-equipped cap that stores injection data.
• OnDosiscoreTechnology or IntegrationOnDosis provides Dosage Manager - an innovative medication delivery and management solution for clinical trial patients. Integrated with MEMS AS for comprehensive adherence monitoring.

Scale indicators6 records

Recent moves6 records

Expansion highlights5 records

Others

• West Pharmaceutical Services: West (formerly Westrock) is a primary AARDEX packaging partner and an integral part of the MEMS AS ecosystem via Dosepak, Cerepak, and Injectapak. It is an ecosystem participant rather than a direct competitor, but could internalize adherence analytics over time.

Emerging players

• Curebase: Curebase provides a decentralized clinical trial platform with eConsent, eCOA, telehealth, and remote patient monitoring. It intersects with AARDEX in the patient-side trial technology layer where adherence is captured and reported.
• YPrime: YPrime provides eCOA, IRT, and clinical technology with a focus on mobile-first and decentralized trials. It overlaps with AARDEX in patient-facing trial technology and serves the same mid-market and enterprise sponsor segment.
• ObvioHealth: ObvioHealth runs fully decentralized clinical trials with its own app-based patient engagement, eCOA, and adherence tools. It targets the same decentralized-trial opportunity AARDEX addresses and is a viable alternative for sponsors.

Direct peers

• Clario: Clario delivers eCOA, cardiac safety, and imaging solutions for clinical trials with adjacent adherence and patient engagement tooling. It competes for the same pharma/CRO procurement budgets and increasingly bundles adherence into broader decentralized trial offerings.
• AiCure: AiCure uses AI-driven facial recognition and computer vision on patient smartphones to confirm medication ingestion in clinical trials. It is a direct adherence-measurement competitor using a different technological approach (vision-based vs. packaging/cap-based).
• Signant Health: Signant Health (formerly CRF Health and Bracket) provides eCOA, ePRO, and patient engagement solutions for clinical trials, including adherence and dosing reminders. It directly overlaps AARDEX in trial-level adherence measurement and serves the same sponsor and CRO buyer base.

Broad incumbents

• IQVIA: IQVIA combines CRO services with its own eClinical technology platform (Orchestrated Patient Engagement, EDC, RTSM). It is both a potential AARDEX buyer/customer (via its CRO arm) and a competitor (via in-house clinical tech).
• Veeva Systems: Veeva offers Vault CTMS, EDC, ePRO, and clinical operations suites. While not focused on adherence specifically, Veeva is a dominant enterprise eClinical vendor that increasingly targets decentralized trial workflows where AARDEX plays.
• Medidata Solutions: Medidata (a Dassault Systèmes company) provides a broad eClinical platform including EDC, IRT, eCOA, and CTMS. As a broad incumbent, it competes by bundling trial-level capabilities and could absorb adherence functionality into its unified Rave platform.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xtwitter.com/aardexgroup
• LinkedInlinkedin.com/company/640230

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about AARDEX Group